Matthew Gall, Chief Financial Officer at iTeos Therapeutics, Inc. (ITOS), sold 5,000 shares at $46.45 ($232K) on 2021-12-27, disclosed to the SEC on 2021-12-28.
Open-market sale of $232k ITOS by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ITOS | BUY | 2021-06-16 | $130K | — | Filing → |